CN Patent

CN104093722B — 作为TBK1和IKK抑制剂的呋喃并[3,2-b]-和噻吩并[3,2-b]吡啶衍生物

Assigned to Merck Patent GmbH · Expires 2016-07-27 · 10y expired

What this patent protects

式(I)化合物为TBK1和IKKε的抑制剂，并可尤其用于治疗癌症和炎性疾病，其中R 1 、R 2 和X具有在权利要求1中指定的意义。

USPTO Abstract

式(I)化合物为TBK1和IKKε的抑制剂，并可尤其用于治疗癌症和炎性疾病，其中R 1 、R 2 和X具有在权利要求1中指定的意义。

Drugs covered by this patent

Patent Metadata

Patent number
CN104093722B
Jurisdiction
CN
Classification
—
Expires
2016-07-27
Drug substance claim
No
Drug product claim
No
Assignee
Merck Patent GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.